论文部分内容阅读
目的探讨神经妥乐平联合普瑞巴林治疗丘脑痛的临床疗效。方法 64例丘脑痛患者随机分成治疗组和对照组,各32例,对照组在常规脑卒中二级预防基础上给予普瑞巴林治疗,治疗组则在对照组基础上加用神经妥乐平,观察两组患者的临床疗效。结果两组的视觉模拟评分(VAS)均较治疗前降低,治疗组降低更明显;治疗组治愈率高于对照组,差异均有统计学意义(P<0.05)。结论神经妥乐平联合普瑞巴林治疗丘脑痛疗效更显著,值得临床推广应用。
Objective To investigate the clinical efficacy of neurotropin combined with pregabalin in the treatment of thalamic pain. Methods 64 cases of thalamic pain were randomly divided into treatment group and control group, 32 cases in each group. The control group was given pregabalin on the basis of secondary prevention of conventional stroke. The treatment group was given neurotropin on the basis of the control group. Clinical efficacy of two groups of patients. Results The visual analogue scale (VAS) of both groups was lower than before treatment, and the treatment group was more obvious. The cure rate of the treatment group was higher than that of the control group (P <0.05). Conclusion Neurotropin combined with pregabalin treatment of thalamic pain more significant effect, worthy of clinical application.